<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>a-radion-note</author_name>
  <author_url>https://blog.hatena.ne.jp/a-radion-note/</author_url>
  <blog_title>放射線治療医　海野しおんの雑記帳</blog_title>
  <blog_url>https://uminoshion.hatenablog.com/</blog_url>
  <categories>
    <anon>前立腺がん</anon>
    <anon>体幹部定位放射線治療</anon>
    <anon>オリゴ転移</anon>
  </categories>
  <description>Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.Phillips R, Shi WY, Deek M, et al. JAMA Oncol. 2020 May 1;6(5):650-659.DOI: 10.1001/jamaoncol.2020.0147. PMID: 32215577; PMCID: PMC7225913. 【背景と目的】・前立腺がんは米国で最も…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fuminoshion.hatenablog.com%2Fentry%2F2025%2F07%2F13%2F100932&quot; title=&quot;オリゴ転移を有する前立腺がん：体幹部定位放射線治療（SABR）vs 経過観察【ORIOLE】 - 放射線治療医　海野しおんの雑記帳&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url>https://cdn-ak.f.st-hatena.com/images/fotolife/a/a-radion-note/20250712/20250712233350.png</image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2025-07-13 10:09:32</published>
  <title>オリゴ転移を有する前立腺がん：体幹部定位放射線治療（SABR）vs 経過観察【ORIOLE】</title>
  <type>rich</type>
  <url>https://uminoshion.hatenablog.com/entry/2025/07/13/100932</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
